港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

艾美疫苗

3.260

+0.0401.24%

成交量：68.36萬

成交額：220.62萬

市值：40.00億

市盈率：-13.35

高：3.270

開：3.240

低：3.200

收：3.220

資料載入中...

總覽公司新聞公告

艾美疫苗(06660.HK)無血清迭代狂犬疫苗上市註冊獲受理

阿斯达克财经

港股公告掘金 | 艾美疫苗研發的無血清迭代狂犬疫苗獲受理上市註冊

【艾美疫苗(06660.HK)研發的無血清迭代狂犬疫苗獲受理上市註冊】艾美疫苗(06660.HK)公佈，該集團研發的無血清迭代狂犬疫苗上市註冊獲國家藥品監督管理局出具的《受理通知書》，受理號：CXSS2500044。此外，該集團全資子公司艾美榮譽(寧波)生物製藥有限公司，已於近日取得無血清迭代狂犬疫苗相應的產品生產許可證。目前，全球市場上尚未有無血清狂犬疫苗獲批上市，該產品有望成為首個上市產品，標誌着集團已取得重大技術突破，進一步鞏固了集團在狂犬疫苗領域的全球領先地位。

艾美疫苗(06660)研發的無血清迭代狂犬疫苗獲受理上市註冊

艾美疫苗盤中異動股價大跌8.50%報3.660港元

《業績》艾美疫苗(06660.HK)全年虧損收窄至2.77億人民幣

阿斯达克财经

艾美疫苗2024年實現收入約12.85億元同比增長8.2% 創新管線全面突破

艾美疫苗03月28日主力淨流出163萬元散戶資金買入

艾美疫苗(06660)股價下跌8.186%，現價港幣$4.15

阿斯达克财经

艾美疫苗03月25日主力淨流入43萬元散户資金拋售

港股異動 | 艾美疫苗(06660)午後漲超9% mRNA帶狀皰疹疫苗獲美國FDA批准開展臨牀

拿下全球市場“通行證”錨定百億藍海艾美mRNA帶狀皰疹疫苗獲美國批准開展臨牀

中国网财经

艾美(06660)又一款重磅大單品mRNA帶狀皰疹疫苗獲美國FDA批准開展臨牀

阿斯利康一天宣佈兩筆交易；艾美疫苗2024年虧損2.5億元-2.9億元

Ofweek光电信息网

港股異動 | 艾美疫苗(06660)現漲超13% 全年虧損同比減少逾85% 多款重磅大單品即將上市

艾美疫苗預計2024年收入為12.5億元至13億元

艾美疫苗：預計2024年業績大幅減虧

艾美疫苗:2024年預計虧損2.5-2.9億元

南方财经网

艾美疫苗(06660.HK)料去年虧損收窄至介乎2.5億至2.9億人幣

阿斯达克财经

格隆匯沽空預警榜 | 3月14日

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06660/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06660","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06660\",,,,,undefined,":{"symbol":"06660","market":"HK","secType":"STK","nameCN":"艾美疫苗","latestPrice":3.26,"timestamp":1745914087035,"preClose":3.22,"halted":0,"volume":683600,"delay":0,"floatShares":508000000,"shares":1227000000,"eps":-0.24421708654263902,"marketStatus":"已收盤","change":0.04,"latestTime":"04-29 16:08:07","open":3.24,"high":3.27,"low":3.2,"amount":2206220,"amplitude":0.021739,"askPrice":3.26,"askSize":1800,"bidPrice":3.24,"bidSize":25000,"shortable":3,"etf":0,"ttmEps":-0.24537247082919564,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745976600000},"marketStatusCode":5,"adr":0,"listingDate":1664985600000,"exchange":"SEHK","adjPreClose":3.22,"openAndCloseTimeList":[[1745890200000,1745899200000],[1745902800000,1745913600000]],"volumeRatio":0.457147,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06660\",,,,,undefined,":{"symbol":"06660","floatShares":508000000,"roa":"-1.96%","roe":"-7.43%","lyrEps":-0.244194,"volumeRatio":0.457147,"shares":1227000000,"dividePrice":0,"high":3.27,"amplitude":0.021739,"preClose":3.22,"low":3.2,"week52Low":3.03,"pbRate":"1.11","psRate":"2.92","week52High":15.48,"institutionHeld":0,"latestPrice":3.26,"committee":0.865672,"eps":-0.24419411729702473,"divideRate":0,"volume":683600,"delay":0,"ttmEps":-0.24534939291671518,"open":3.24,"prevYearClose":6.14,"prevWeekClose":3.29,"prevMonthClose":4.15,"prevQuarterClose":4.15,"fiveDayClose":3.28,"twentyDayClose":4.52,"sixtyDayClose":5.87},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06660\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525232024","title":"艾美疫苗(06660.HK)無血清迭代狂犬疫苗上市註冊獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2525232024","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525232024?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 00:56","pubTimestamp":1744044960,"startTime":"0","endTime":"0","summary":"艾美疫苗(06660.HK) 公布，集团研发的无血清迭代狂犬疫苗上市注册获国家药品监督管理局受理。此外，全资子公司艾美荣誉(宁波)已于近日取得无血清迭代狂犬疫苗相应的产品生产许可证。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-07 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221108125355599_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221108125355599_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1432152/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159646","BK1161","06660"],"gpt_icon":0},{"id":"2525281330","title":"港股公告掘金 | 艾美疫苗研發的無血清迭代狂犬疫苗獲受理上市註冊","url":"https://stock-news.laohu8.com/highlight/detail?id=2525281330","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525281330?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 23:02","pubTimestamp":1744038173,"startTime":"0","endTime":"0","summary":"【重大事项】传承教育集团(08195)拟转至主板上市天机控股(01520)拟收购信桥资本集团不超15%股权艾美疫苗(06660)研发的无血清迭代狂犬疫苗获受理上市注册金源氢化(02502)：金马焦化拟出售金马香港全部股份 4月8日复牌狮腾控股(02562)订立具约束力独家认购期权以收购中国AI公司高达100%股权中国抗体-B(03681)：SM17在中国治疗中重度特异性皮炎的 1B期临床试验的积极","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0593848301.USD","LU0877626530.USD","BK1161","IE00BZ08YS42.EUR","LU2048586759.USD","LU0862451753.SGD","HSTECH","BK1110","LU1655091616.SGD","LU2476274308.USD","IE00B29SXG58.USD","LU0205439572.USD","03933","BK1183","IE00B543WZ88.USD","BK1214","06690","LU0890818403.SGD","IE00BZ08YT58.USD","BK1613","06660","01907","BK1607","BK1557","LU0868486357.SGD","LU2279701549.SGD","BK4614","IE00BPRC5H50.USD","IE00BMCWC346.EUR","IE0034224299.USD","159646","BK1191","YANG","IE00BZ08YR35.GBP","LU0431992006.USD","BK1109","IE00BYV24P56.USD","IE0008369823.USD","IE00B5MMRT66.SGD","02121","LU2778985437.USD","LU1119993845.HKD"],"gpt_icon":1},{"id":"2525116040","title":"【艾美疫苗(06660.HK)研發的無血清迭代狂犬疫苗獲受理上市註冊】艾美疫苗(06660.HK)公佈，該集團研發的無血清迭代狂犬疫苗上市註冊獲國家藥品監督管理局出具的《受理通知書》，受理號：CXSS2500044。此外，該集團全資子公司艾美榮譽(寧波)生物製藥有限公司，已於近日取得無血清迭代狂犬疫苗相應的產品生產許可證。目前，全球市場上尚未有無血清狂犬疫苗獲批上市，該產品有望成為首個上市產品，標誌着集團已取得重大技術突破，進一步鞏固了集團在狂犬疫苗領域的全球領先地位。","url":"https://stock-news.laohu8.com/highlight/detail?id=2525116040","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525116040?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 22:58","pubTimestamp":1744037908,"startTime":"0","endTime":"0","summary":"艾美疫苗(06660.HK)公布，该集团研发的无血清迭代狂犬疫苗上市注册获国家药品监督管理局出具的《受理通知书》，受理号：CXSS2500044。此外，该集团全资子公司艾美荣誉(宁波)生物制药有限公司，已于近日取得无血清迭代狂犬疫苗相应的产品生产许可证。目前，全球市场上尚未有无血清狂犬疫苗获批上市，该产品有望成为首个上市产品，标志着集团已取得重大技术突破，进一步巩固了集团在狂犬疫苗领域的全球领先地位。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/07225849360612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159646","BK1161","06660"],"gpt_icon":0},{"id":"2525040638","title":"艾美疫苗(06660)研發的無血清迭代狂犬疫苗獲受理上市註冊","url":"https://stock-news.laohu8.com/highlight/detail?id=2525040638","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525040638?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 22:50","pubTimestamp":1744037418,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾美疫苗 公布，该集团研发的无血清迭代狂犬疫苗上市注册获国家药品监督管理局出具的《受理通知书》，受理号：CXSS2500044。此外，该集团全资子公司艾美荣誉(宁波)生物制药有限公司，已于近日取得无血清迭代狂犬疫苗相应的产品生产许可证。狂犬疫苗有两种，一种是有血清狂犬疫苗，一种是无血清狂犬疫苗，但目前全球尚无任何一款无血清狂犬疫苗注册上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","BK1161","06660"],"gpt_icon":0},{"id":"2525036971","title":"艾美疫苗盤中異動 股價大跌8.50%報3.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525036971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525036971?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 09:33","pubTimestamp":1743989609,"startTime":"0","endTime":"0","summary":"2025年04月07日早盘09时33分，艾美疫苗股票出现异动，股价急速跳水8.50%。截至发稿，该股报3.660港元/股，成交量4.64万股，换手率0.01%，振幅3.50%。资金方面，该股资金流入0港元，流出9.718万港元。艾美疫苗股票所在的药品行业中，整体跌幅为1.92%。其相关个股中，衍生集团、中智药业、中生联合涨幅较大，振幅较大的相关个股有亿胜生物科技、德琪医药-B、联康生物科技集团，振幅分别为12.60%、12.31%、8.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093329aa2c5d4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407093329aa2c5d4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2523128675","title":"《業績》艾美疫苗(06660.HK)全年虧損收窄至2.77億人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2523128675","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523128675?lang=zh_tw&edition=fundamental","pubTime":"2025-03-30 17:47","pubTimestamp":1743328020,"startTime":"0","endTime":"0","summary":"艾美疫苗(06660.HK) 公布2024年度业绩，收入录得12.85亿人民币(下同)，按年增加8.2%。亏损由上年度13.01亿元，收窄至2.77亿元，每股亏损23分。不派末期息。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-28 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩无派息2024/03/28末期业绩无派息2023/08/29中期业绩无派息2023/03/29末期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221108125356747_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221108125356747_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1429778/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2522705475","title":"艾美疫苗2024年實現收入約12.85億元 同比增長8.2% 創新管線全面突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2522705475","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522705475?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 21:14","pubTimestamp":1743167695,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾美疫苗 公布2024年业绩，收入约12.85亿元，同比增长8.2%。净亏损约2.78亿元，同比收窄85.7%。经营活动净现金流净流入近1亿元。其中，主营业务收入为12.85亿元，同比上升8.2%。上升主要是因为公司乙肝、甲肝及四价流脑疫苗产品的销售收入均实现增长。研发支出为3.63亿元，同比下降42.9%。在售产品中，公司已上市的甲肝疫苗、乙肝疫苗和狂犬疫苗为世界卫生组织中优先认证的产品，这些产品均受到国际市场青睐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503282132079726ae16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503282132079726ae16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2522547971","title":"艾美疫苗03月28日主力淨流出163萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2522547971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522547971?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 16:16","pubTimestamp":1743149812,"startTime":"0","endTime":"0","summary":"03月28日, 艾美疫苗股价跌6.86%，报收4.21元，成交金额925万元，换手率0.43%，振幅9.29%，量比1.43。艾美疫苗今日主力资金（超大单+大单）净流出163万元，上一交易日主力净流出0万元。该股近5个交易日上涨3.95%，主力资金累计净流出120万元；近20日主力资金累计净流出1253万元，其中净流出天数为7日。该股主力净额占比0.08%（主力资金净额/流通市值），港股市场排名2560/2650。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165830a6a734cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165830a6a734cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2522518296","title":"艾美疫苗(06660)股價下跌8.186%，現價港幣$4.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2522518296","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522518296?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 13:55","pubTimestamp":1743141300,"startTime":"0","endTime":"0","summary":"[下跌股]艾美疫苗(06660) 股价在下午01:55比前收市价下跌8.186%，现股价为港币$4.15。至目前为止，今日最高价为$4.57，而最低价为$4.15。总成交量为179.5万股，总成交金额为港币$773.208万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2503283007/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2522001970","title":"艾美疫苗03月25日主力淨流入43萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2522001970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522001970?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 16:15","pubTimestamp":1742890547,"startTime":"0","endTime":"0","summary":"03月25日, 艾美疫苗股价涨5.32%，报收4.55元，成交金额1139万元，换手率0.50%，振幅12.50%，量比1.29。艾美疫苗今日主力资金净流入43万元，上一交易日主力净流出0万元。该股近5个交易日上涨13.40%，主力资金累计净流入106万元；近20日主力资金累计净流出724万元，其中净流出天数为8日。该股主力净额占比0.02%，港股市场排名213/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250325165351a6a329b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250325165351a6a329b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2522693310","title":"港股異動 | 艾美疫苗(06660)午後漲超9% mRNA帶狀皰疹疫苗獲美國FDA批准開展臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2522693310","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522693310?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 13:51","pubTimestamp":1742881900,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾美疫苗午后涨超9%，截至发稿，涨5.32%，报4.55港元，成交额876.35万港元。消息面上，艾美疫苗3月23日发布公告称，mRNA带状疱疹疫苗已于近日获得美国药监局 临床试验许可，这是继mRNA RSV疫苗后，短期内公司第二款获得美国FDA批准进入临床试验的又一重磅大单品疫苗，巩固了艾美在mRNA技术赛道的领跑地位，标志着国际化战略又取得了新的里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06660","159646"],"gpt_icon":0},{"id":"2521806527","title":"拿下全球市場“通行證”錨定百億藍海 艾美mRNA帶狀皰疹疫苗獲美國批准開展臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2521806527","media":"中国网财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521806527?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 07:58","pubTimestamp":1742774280,"startTime":"0","endTime":"0","summary":"3月23日艾美疫苗发布公告称，mRNA带状疱疹疫苗已于近日获得美国药监局临床试验许可。艾美mRNA疫苗技术平台再获国际权威机构认可继mRNA RSV疫苗美国获批开展临床之后，艾美自主研发的mRNA带状疱疹疫苗也迅速获美国FDA批准开展临床。拿mRNA带状疱疹疫苗来说，目前国际上尚无同款技术路线的带状疱疹疫苗获批上市，带状疱疹疫苗在目标人群中接种率仅为0.1%左右，存在巨大提升空间。该产品获批上市后，将给艾美疫苗带来可观的业绩增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503240801549720baab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503240801549720baab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2521782040","title":"艾美(06660)又一款重磅大單品mRNA帶狀皰疹疫苗獲美國FDA批准開展臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2521782040","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521782040?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 07:25","pubTimestamp":1742772345,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾美疫苗3月23日发布公告称，mRNA带状疱疹疫苗已于近日获得美国药监局 临床试验许可，这是继mRNA RSV疫苗后，短期内公司第二款获得美国FDA批准进入临床试验的又一重磅大单品疫苗，巩固了艾美在mRNA技术赛道的领跑地位，标志着国际化战略又取得了新的里程碑。接种带状疱疹疫苗是抑制带状疱疹发病的有效措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","BK1161","06660"],"gpt_icon":0},{"id":"2520667093","title":"阿斯利康一天宣佈兩筆交易；艾美疫苗2024年虧損2.5億元-2.9億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2520667093","media":"Ofweek光电信息网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520667093?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 13:47","pubTimestamp":1742276820,"startTime":"0","endTime":"0","summary":"阿斯利康积极布局未来。3月17日，阿斯利康官宣了两笔交易。艾美疫苗发布2024年业绩预告。3月17日，艾美疫苗公告表示，报告期内，公司预计收入12.5亿元至13亿元之间，较上一年度增加5%至9%；净亏损介乎2.5亿元至2.9亿元之间。QL2108是首个进入III期临床阶段的度普利尤单抗生物类似药。一是宣布收购体内细胞疗法公司EsoBiotec，代价为4.25亿美元首付款，以及最高5.75亿美元的基于开发和监管里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031813540594b84712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031813540594b84712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU1829250122.USD","AZN","LU2236285917.USD","BK4585","LU2462157665.USD","BK4588","LU0320765992.SGD","LU2456880835.USD","LU0889565916.HKD","LU0109394709.USD","LU2417539215.USD","BK4007","06660"],"gpt_icon":0},{"id":"2520562652","title":"港股異動 | 艾美疫苗(06660)現漲超13% 全年虧損同比減少逾85% 多款重磅大單品即將上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2520562652","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520562652?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 14:55","pubTimestamp":1742194552,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾美疫苗现涨超13%，截至发稿，涨12.78%，报3.97港元，成交额1851.32万港元。消息面上，艾美疫苗发布公告称，公司2024年录得收入12.5亿至13亿之间，同比增加5%至9%；净亏损介乎人民币2.5亿元至2.9亿元之间，减亏幅度85%至87%。国证国际认为，艾美未来三年预计每年将有1-2款产品上市，若在研产品陆续成功获批上市，同时产品出海进展顺利，有望为公司带来新的财报增长点并打开市场天花板。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1262714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 艾美疫苗(06660)现涨超13% 全年亏损同比减少逾85% 多款重磅大单品即将上市","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2520355590","title":"艾美疫苗預計2024年收入為12.5億元至13億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2520355590","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520355590?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 10:15","pubTimestamp":1742177713,"startTime":"0","endTime":"0","summary":"3月17日，艾美疫苗（06660）发布公告，预计截至2024年12月31日的报告期间，本集团未经审计的收入将介于12.5亿元至13亿元之间，较上一年度的11.9亿元增加6000万至1.1亿，增幅为5%至9%。同时，预计未审计的净亏损将介于2.5亿元至2.9亿元，较上一年度的净亏损19.5亿元大幅减少，减亏幅度为85%至87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503173347407027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2520539294","title":"艾美疫苗：預計2024年業績大幅減虧","url":"https://stock-news.laohu8.com/highlight/detail?id=2520539294","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520539294?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 09:06","pubTimestamp":1742173587,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2520539362","title":"艾美疫苗:2024年預計虧損2.5-2.9億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2520539362","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520539362?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 08:52","pubTimestamp":1742172761,"startTime":"0","endTime":"0","summary":"南方财经3月17日电，艾美疫苗公告，预计公司2024年录得收入12.5亿至13亿之间，较上一年度增加5%至9%；净亏损介乎人民币2.5亿元至2.9亿元之间，减亏幅度85%至87%。减亏主要原因是大额资产减值损失金额减少，以及由乙肝疫苗带动的收入增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503173347039321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2520539693","title":"艾美疫苗(06660.HK)料去年虧損收窄至介乎2.5億至2.9億人幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2520539693","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520539693?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 08:50","pubTimestamp":1742172600,"startTime":"0","endTime":"0","summary":"艾美疫苗(06660.HK) 公布，预期截至2024年12月31日，将录得未经审核收入介乎12.5亿至13亿元人民币(下同)，较上一年度收入11.9亿元，增加6,000万至1.1亿元，增幅为5%至9%；未经审核净亏损介乎2.5亿至2.9亿元之间，较上一年度净亏损19.5亿元，大幅减亏16.6亿至17亿元，减亏幅度为85%至87%。公告指，收入增加主要由于公司乙肝疫苗收入增加；至于综合净亏损减少主要由于本年度大额资产减值损失金额减少、收入增加。(js/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-14 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221108125355599_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221108125355599_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1425014/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2519348647","title":"格隆匯沽空預警榜 | 3月14日","url":"https://stock-news.laohu8.com/highlight/detail?id=2519348647","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519348647?lang=zh_tw&edition=fundamental","pubTime":"2025-03-16 02:15","pubTimestamp":1742062500,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为16.02%，过去两个月大市日均沽空比例为17.42%。其中，安硕亚洲除日-R、安硕恒生指数-R、PP国债-U沽空比率排名前三位，分别为100.00%、100.00%、100.00%。比亚迪股份、南方恒生科技、腾讯控股的沽空金额排名前三位，分别为30.68亿、29.56亿、25.62亿。兖煤澳大利亚、和记电讯香港、载通的偏离值排名前三位，分别为5.24、4.53、4.00。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/16021548779068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PNGAY","HBBD.SI","02800","09988","HTCD.SI","03033","01072","01211","80700","02158","81211","09807","LU0608807946.USD","09817","06660","LU1242518857.USD","02429","09403","03668","83111","03010","03066","00215","TCEHY","00086","601318","AAGIY","00700","BABA","89988","HXXD.SI","01299","03145","HMTD.SI","03011","82318","00062","03171","002594","HYDD.SI","BYDDY","81299","HPAD.SI","81810"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06660\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"06660","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"盤前","dateTimestamp":1743091200000,"actualEps":null},{"market":"HK","date":"2024-08-29","symbol":"06660","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1724860800000,"reportTimeType":"pre","actualEps":null},{"date":"2024-03-27","symbol":"06660","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-29","symbol":"06660","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null},{"date":"2023-03-29","symbol":"06660","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1680053400000,"name":null,"time":"","dateTimestamp":1680019200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06660\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06660\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06660\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06660","date":"2025-04-28","current":-13.399234,"percent":0.604466,"low":-187.43982,"twenty":-66.810324,"median":-16.66487,"eighty":-6.875078,"high":-3.339461,"avg":-42.570135,"sd":53.295839,"marketCap":3949531568},"quantilePoints":[{"date":"2022-10-07","current":-39.249404,"twenty":-34.09538,"median":-26.364344,"eighty":-25.88985,"marketCap":30000907175},{"date":"2022-10-14","current":-30.712392,"twenty":-49.650828,"median":-31.171394,"eighty":-26.513759,"marketCap":23226508780},{"date":"2022-10-21","current":-33.259584,"twenty":-36.853476,"median":-31.630397,"eighty":-28.327686,"marketCap":24980594079},{"date":"2022-10-28","current":-34.726702,"twenty":-34.211619,"median":-32.376619,"eighty":-30.822896,"marketCap":26037845878},{"date":"2022-11-04","current":-45.909375,"twenty":-47.589109,"median":-33.192557,"eighty":-31.069435,"marketCap":34757496591},{"date":"2022-11-11","current":-35.356659,"twenty":-45.364312,"median":-34.082848,"eighty":-31.273366,"marketCap":27006695957},{"date":"2022-11-18","current":-38.023721,"twenty":-44.303189,"median":-36.283105,"eighty":-31.490659,"marketCap":28944396116},{"date":"2022-11-25","current":-37.044858,"twenty":-43.603562,"median":-37.128864,"eighty":-31.814002,"marketCap":27975546036},{"date":"2022-12-02","current":-37.992821,"twenty":-42.418127,"median":-37.070902,"eighty":-32.319177,"marketCap":29186608635},{"date":"2022-12-09","current":-39.048931,"twenty":-43.446552,"median":-37.293796,"eighty":-32.821116,"marketCap":30276564975},{"date":"2022-12-16","current":-37.809462,"twenty":-43.069902,"median":-37.473139,"eighty":-33.11125,"marketCap":29247161765},{"date":"2022-12-23","current":-36.389081,"twenty":-42.369889,"median":-37.6413,"eighty":-33.219368,"marketCap":28157205426},{"date":"2022-12-30","current":-36.802773,"twenty":-41.392227,"median":-37.325605,"eighty":-33.259584,"marketCap":28823289856},{"date":"2023-01-06","current":-38.265257,"twenty":-40.9501,"median":-37.325605,"eighty":-33.403112,"marketCap":30276564975},{"date":"2023-01-13","current":-34.693589,"twenty":-40.562862,"median":-37.237427,"eighty":-33.403112,"marketCap":27975546036},{"date":"2023-01-20","current":-35.902804,"twenty":-40.449861,"median":-37.070902,"eighty":-33.957584,"marketCap":28702183596},{"date":"2023-01-27","current":-35.28963,"twenty":-40.355385,"median":-37.044858,"eighty":-34.121177,"marketCap":28217758556},{"date":"2023-02-03","current":-40.682891,"twenty":-40.355385,"median":-37.015617,"eighty":-34.049749,"marketCap":32698690173},{"date":"2023-02-10","current":-39.185562,"twenty":-39.942689,"median":-37.008822,"eighty":-34.121177,"marketCap":31305968184},{"date":"2023-02-17","current":-39.789297,"twenty":-40.482729,"median":-37.05788,"eighty":-34.33261,"marketCap":31487627574},{"date":"2023-02-24","current":-44.619807,"twenty":-41.242911,"median":-37.212869,"eighty":-34.646897,"marketCap":34878602851},{"date":"2023-03-03","current":-40.023691,"twenty":-41.382531,"median":-37.295788,"eighty":-34.700212,"marketCap":31487627574},{"date":"2023-03-10","current":-54.899003,"twenty":-49.920873,"median":-44.670569,"eighty":-42.730326,"marketCap":42871616004},{"date":"2023-03-17","current":-63.511874,"twenty":-43.021664,"median":-37.80986,"eighty":-35.244194,"marketCap":50077438468},{"date":"2023-03-24","current":-66.207638,"twenty":-43.779521,"median":-38.008271,"eighty":-35.28963,"marketCap":52802329316},{"date":"2023-03-31","current":-118.353602,"twenty":-44.619807,"median":-38.265257,"eighty":-35.306041,"marketCap":43212851825},{"date":"2023-04-06","current":-113.439206,"twenty":-46.186473,"median":-38.377932,"eighty":-35.336412,"marketCap":41391809095},{"date":"2023-04-14","current":-118.178415,"twenty":-52.607816,"median":-38.519316,"eighty":-35.40708,"marketCap":43163634454},{"date":"2023-04-21","current":-113.520451,"twenty":-57.717067,"median":-39.048931,"eighty":-35.555127,"marketCap":41441026466},{"date":"2023-04-28","current":-145.393592,"twenty":-62.256199,"median":-39.357069,"eighty":-35.759371,"marketCap":52681223056},{"date":"2023-05-05","current":-140.1502,"twenty":-63.696189,"median":-39.708766,"eighty":-35.905234,"marketCap":50864629158},{"date":"2023-05-12","current":-152.546139,"twenty":-70.445818,"median":-40.023691,"eighty":-35.941318,"marketCap":54982241994},{"date":"2023-05-19","current":-160.68573,"twenty":-114.2544,"median":-40.466295,"eighty":-36.094035,"marketCap":57101601542},{"date":"2023-05-25","current":-149.885812,"twenty":-114.944342,"median":-40.725934,"eighty":-36.283105,"marketCap":53044541836},{"date":"2023-06-02","current":-175.805136,"twenty":-118.353602,"median":-41.343747,"eighty":-36.304775,"marketCap":62006405068},{"date":"2023-06-09","current":-149.925362,"twenty":-138.391284,"median":-42.160895,"eighty":-36.311194,"marketCap":52802329316},{"date":"2023-06-16","current":-162.39452,"twenty":-139.889015,"median":-42.678956,"eighty":-36.322688,"marketCap":56919942153},{"date":"2023-06-23","current":-157.205354,"twenty":-141.823788,"median":-42.779449,"eighty":-36.363673,"marketCap":54800582604},{"date":"2023-06-30","current":-157.238029,"twenty":-147.26406,"median":-43.102061,"eighty":-36.406274,"marketCap":54316157565},{"date":"2023-07-07","current":-153.857018,"twenty":-150.35033,"median":-43.739717,"eighty":-36.466537,"marketCap":53044541836},{"date":"2023-07-14","current":-152.247525,"twenty":-152.00784,"median":-43.937896,"eighty":-36.500101,"marketCap":53226201226},{"date":"2023-07-21","current":-160.092989,"twenty":-152.667847,"median":-44.830488,"eighty":-36.525459,"marketCap":55708879554},{"date":"2023-07-28","current":-187.43982,"twenty":-153.311238,"median":-46.255747,"eighty":-36.57824,"marketCap":65155167826},{"date":"2023-08-04","current":-177.91145,"twenty":-154.591644,"median":-49.171035,"eighty":-36.679656,"marketCap":61945851938},{"date":"2023-08-11","current":-180.14599,"twenty":-156.363915,"median":-56.986688,"eighty":-36.771127,"marketCap":62369723848},{"date":"2023-08-18","current":-181.621253,"twenty":-157.969192,"median":-57.859931,"eighty":-36.885193,"marketCap":62430276978},{"date":"2023-08-25","current":-172.551893,"twenty":-160.092861,"median":-60.493446,"eighty":-37.014258,"marketCap":59342067351},{"date":"2023-09-01","current":-105.444286,"twenty":-160.092861,"median":-63.48672,"eighty":-37.03139,"marketCap":59826492390},{"date":"2023-09-08","current":-90.716957,"twenty":-160.023191,"median":-64.974953,"eighty":-37.055276,"marketCap":50864629158},{"date":"2023-09-15","current":-83.589059,"twenty":-159.758121,"median":-67.999114,"eighty":-37.086946,"marketCap":47231441361},{"date":"2023-09-22","current":-85.032499,"twenty":-158.921155,"median":-79.053894,"eighty":-37.151754,"marketCap":47836972660},{"date":"2023-09-29","current":-61.999684,"twenty":-157.969192,"median":-72.530684,"eighty":-37.232516,"marketCap":34939155981},{"date":"2023-10-06","current":-48.806486,"twenty":-157.752838,"median":-71.057494,"eighty":-37.262783,"marketCap":27491120997},{"date":"2023-10-13","current":-23.59997,"twenty":-157.231494,"median":-66.709876,"eighty":-37.050067,"marketCap":13273246085},{"date":"2023-10-20","current":-18.503669,"twenty":-157.043466,"median":-63.742268,"eighty":-36.760578,"marketCap":10390917099},{"date":"2023-10-27","current":-20.065032,"twenty":-156.395913,"median":-63.511874,"eighty":-36.500788,"marketCap":11262882170},{"date":"2023-11-03","current":-19.151169,"twenty":-156.315919,"median":-62.658333,"eighty":-36.325562,"marketCap":10778457131},{"date":"2023-11-10","current":-18.810809,"twenty":-156.013178,"median":-60.665026,"eighty":-36.046768,"marketCap":10584687115},{"date":"2023-11-17","current":-19.367901,"twenty":-155.651386,"median":-58.132397,"eighty":-35.482712,"marketCap":10996448398},{"date":"2023-11-24","current":-19.29438,"twenty":-154.793074,"median":-57.388264,"eighty":-35.244194,"marketCap":11044890902},{"date":"2023-12-01","current":-18.076992,"twenty":-154.289499,"median":-53.362157,"eighty":-34.256956,"marketCap":10390917099},{"date":"2023-12-08","current":-17.240718,"twenty":-153.857018,"median":-48.806486,"eighty":-33.438994,"marketCap":9870160181},{"date":"2023-12-15","current":-16.82624,"twenty":-153.737112,"median":-46.255747,"eighty":-33.026282,"marketCap":9688500792},{"date":"2023-12-22","current":-14.122442,"twenty":-153.322724,"median":-44.619807,"eighty":-31.397501,"marketCap":8126230039},{"date":"2023-12-29","current":-16.434159,"twenty":-153.305494,"median":-44.242307,"eighty":-30.878147,"marketCap":9506841402},{"date":"2024-01-05","current":-16.382214,"twenty":-153.191313,"median":-43.858362,"eighty":-26.273538,"marketCap":9409956394},{"date":"2024-01-12","current":-16.141697,"twenty":-152.962526,"median":-43.676212,"eighty":-23.818608,"marketCap":9276739508},{"date":"2024-01-19","current":-15.488646,"twenty":-152.728701,"median":-42.920772,"eighty":-20.763613,"marketCap":8889199476},{"date":"2024-01-26","current":-15.252583,"twenty":-152.529425,"median":-42.717288,"eighty":-19.973176,"marketCap":8719650712},{"date":"2024-02-02","current":-14.338762,"twenty":-152.401622,"median":-42.160895,"eighty":-19.766336,"marketCap":8186783169},{"date":"2024-02-09","current":-13.804134,"twenty":-152.191477,"median":-41.343747,"eighty":-19.441349,"marketCap":7920349397},{"date":"2024-02-16","current":-14.328717,"twenty":-152.107405,"median":-40.804273,"eighty":-19.29438,"marketCap":8223115047},{"date":"2024-02-23","current":-14.256152,"twenty":-151.941463,"median":-40.493685,"eighty":-19.151169,"marketCap":8138340665},{"date":"2024-03-01","current":-16.876226,"twenty":-151.901114,"median":-40.077081,"eighty":-19.025548,"marketCap":9640058288},{"date":"2024-03-08","current":-16.635614,"twenty":-151.782948,"median":-39.789297,"eighty":-18.810809,"marketCap":9506841402},{"date":"2024-03-15","current":-17.90178,"twenty":-150.987781,"median":-39.357069,"eighty":-18.23601,"marketCap":10221368335},{"date":"2024-03-22","current":-17.026507,"twenty":-149.925362,"median":-39.048931,"eighty":-18.076992,"marketCap":9712722043},{"date":"2024-03-28","current":-17.31542,"twenty":-149.893722,"median":-38.581864,"eighty":-17.898537,"marketCap":9845938929},{"date":"2024-04-05","current":-7.320072,"twenty":-149.759658,"median":-38.447436,"eighty":-17.720419,"marketCap":10306142717},{"date":"2024-04-12","current":-7.22995,"twenty":-149.268804,"median":-38.265257,"eighty":-17.34028,"marketCap":10185036457},{"date":"2024-04-19","current":-7.098461,"twenty":-147.781497,"median":-38.008271,"eighty":-17.033692,"marketCap":9991266441},{"date":"2024-04-26","current":-7.107224,"twenty":-145.89495,"median":-37.80986,"eighty":-16.866103,"marketCap":9991266441},{"date":"2024-05-03","current":-7.655248,"twenty":-145.339837,"median":-37.473139,"eighty":-16.788307,"marketCap":10754235879},{"date":"2024-05-10","current":-10.073333,"twenty":-144.566257,"median":-37.295788,"eighty":-16.647316,"marketCap":9954934563},{"date":"2024-05-17","current":-9.854959,"twenty":-142.332023,"median":-37.237427,"eighty":-16.497031,"marketCap":9724832669},{"date":"2024-05-24","current":-9.077968,"twenty":-141.484964,"median":-37.070902,"eighty":-16.338636,"marketCap":8937641980},{"date":"2024-05-31","current":-8.110254,"twenty":-141.466686,"median":-37.015617,"eighty":-15.826059,"marketCap":7993013153},{"date":"2024-06-07","current":-8.477126,"twenty":-140.1502,"median":-36.750029,"eighty":-15.525484,"marketCap":8344221307},{"date":"2024-06-14","current":-8.731197,"twenty":-139.889015,"median":-36.541907,"eighty":-15.339753,"marketCap":8586433826},{"date":"2024-06-21","current":-8.860579,"twenty":-139.73255,"median":-36.458404,"eighty":-15.207111,"marketCap":8695429460},{"date":"2024-06-28","current":-8.666724,"twenty":-139.104224,"median":-36.325562,"eighty":-14.908984,"marketCap":8501659444},{"date":"2024-07-05","current":-8.446334,"twenty":-138.615906,"median":-36.304775,"eighty":-14.645053,"marketCap":8283668177},{"date":"2024-07-12","current":-8.520258,"twenty":-128.736138,"median":-35.980862,"eighty":-14.347392,"marketCap":8368442559},{"date":"2024-07-19","current":-8.014564,"twenty":-120.263813,"median":-35.663749,"eighty":-14.225966,"marketCap":7871906893},{"date":"2024-07-26","current":-7.87434,"twenty":-118.739827,"median":-35.33135,"eighty":-14.078648,"marketCap":7762911259},{"date":"2024-08-02","current":-8.444345,"twenty":-118.463573,"median":-35.244194,"eighty":-13.841389,"marketCap":8320000055},{"date":"2024-08-09","current":-7.729085,"twenty":-118.24849,"median":-34.664406,"eighty":-13.601323,"marketCap":7666026251},{"date":"2024-08-16","current":-7.152424,"twenty":-117.684621,"median":-34.087232,"eighty":-10.427106,"marketCap":7096826830},{"date":"2024-08-23","current":-5.675979,"twenty":-117.266486,"median":-33.70307,"eighty":-10.129645,"marketCap":5655662337},{"date":"2024-08-30","current":-4.178129,"twenty":-115.849483,"median":-33.192557,"eighty":-9.578108,"marketCap":5461892321},{"date":"2024-09-06","current":-3.963145,"twenty":-114.802816,"median":-32.845056,"eighty":-9.118412,"marketCap":5183347923},{"date":"2024-09-13","current":-3.843571,"twenty":-114.642804,"median":-31.630397,"eighty":-8.8611,"marketCap":5013799159},{"date":"2024-09-20","current":-3.931402,"twenty":-114.534572,"median":-31.19061,"eighty":-8.79795,"marketCap":5159126671},{"date":"2024-09-27","current":-5.247227,"twenty":-114.070913,"median":-28.725137,"eighty":-8.723808,"marketCap":6927278066},{"date":"2024-10-04","current":-9.952559,"twenty":-113.504202,"median":-26.288672,"eighty":-8.721345,"marketCap":13079476069},{"date":"2024-10-10","current":-6.223788,"twenty":-113.439206,"median":-25.18909,"eighty":-8.713229,"marketCap":8126230039},{"date":"2024-10-18","current":-6.526806,"twenty":-105.444286,"median":-23.80599,"eighty":-8.659999,"marketCap":8477438193},{"date":"2024-10-25","current":-7.403732,"twenty":-105.440743,"median":-21.181743,"eighty":-8.500637,"marketCap":9615837036},{"date":"2024-11-01","current":-7.790115,"twenty":-102.633989,"median":-20.408235,"eighty":-8.454325,"marketCap":10124483327},{"date":"2024-11-08","current":-7.483401,"twenty":-101.592755,"median":-19.988485,"eighty":-8.421637,"marketCap":9652168914},{"date":"2024-11-15","current":-6.613215,"twenty":-100.707223,"median":-19.905056,"eighty":-8.307742,"marketCap":8465327567},{"date":"2024-11-22","current":-6.209335,"twenty":-96.82491,"median":-19.729301,"eighty":-8.173929,"marketCap":7944570649},{"date":"2024-11-29","current":-6.857585,"twenty":-93.142743,"median":-19.55152,"eighty":-8.069467,"marketCap":8768093216},{"date":"2024-12-06","current":-6.484514,"twenty":-90.716957,"median":-19.298474,"eighty":-7.993821,"marketCap":8271557551},{"date":"2024-12-13","current":-6.243356,"twenty":-90.558474,"median":-19.187955,"eighty":-7.879753,"marketCap":7956681275},{"date":"2024-12-20","current":-6.096269,"twenty":-89.542812,"median":-19.150047,"eighty":-7.829898,"marketCap":7726579381},{"date":"2024-12-27","current":-5.804558,"twenty":-88.879602,"median":-19.098041,"eighty":-7.765703,"marketCap":7351149975},{"date":"2025-01-03","current":-5.588707,"twenty":-88.012004,"median":-19.025548,"eighty":-7.652055,"marketCap":7084716204},{"date":"2025-01-10","current":-5.13048,"twenty":-86.775794,"median":-18.986028,"eighty":-7.575924,"marketCap":6479184904},{"date":"2025-01-17","current":-5.183834,"twenty":-85.540257,"median":-18.61875,"eighty":-7.496967,"marketCap":6551848660},{"date":"2025-01-24","current":-5.2563,"twenty":-84.969771,"median":-18.40199,"eighty":-7.416118,"marketCap":6685065546},{"date":"2025-01-28","current":-5.496679,"twenty":-84.907043,"median":-18.269472,"eighty":-7.345573,"marketCap":7024163074},{"date":"2025-02-07","current":-5.611132,"twenty":-84.0957,"median":-18.103593,"eighty":-7.273488,"marketCap":7133158708},{"date":"2025-02-14","current":-5.595916,"twenty":-83.651388,"median":-18.025453,"eighty":-7.229568,"marketCap":7096826830},{"date":"2025-02-21","current":-5.717349,"twenty":-82.830009,"median":-17.885563,"eighty":-7.174275,"marketCap":7290596845},{"date":"2025-02-28","current":-5.450394,"twenty":-82.037605,"median":-17.683366,"eighty":-7.114351,"marketCap":6927278066},{"date":"2025-03-07","current":-4.773751,"twenty":-77.354063,"median":-17.37757,"eighty":-7.045911,"marketCap":6091644872},{"date":"2025-03-14","current":-3.339461,"twenty":-75.647588,"median":-17.189742,"eighty":-7.020279,"marketCap":4262940348},{"date":"2025-03-21","current":-3.843787,"twenty":-73.125402,"median":-17.026507,"eighty":-6.892571,"marketCap":4904803525},{"date":"2025-03-28","current":-4.003742,"twenty":-71.937828,"median":-16.906589,"eighty":-6.83266,"marketCap":5098573541},{"date":"2025-04-03","current":-16.530137,"twenty":-71.350342,"median":-16.86779,"eighty":-6.842031,"marketCap":4906250396},{"date":"2025-04-11","current":-13.718818,"twenty":-69.222466,"median":-16.812265,"eighty":-6.843784,"marketCap":4035390950},{"date":"2025-04-17","current":-13.325873,"twenty":-67.684314,"median":-16.777279,"eighty":-6.849564,"marketCap":3925000316},{"date":"2025-04-25","current":-13.674176,"twenty":-67.011219,"median":-16.694126,"eighty":-6.866332,"marketCap":4035390950},{"date":"2025-04-28","current":-13.399234,"twenty":-66.810324,"median":-16.66487,"eighty":-6.875078,"marketCap":3949531568}],"updateTime":1745923551761}}}